USH.1.H.iPSC.6

General

Cell Line

hPSCreg name RIi011-A
Cite as:
RIi011-A (RRID:CVCL_C373)
Alternative name(s)
USH.1.H.iPSC.6
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
WTSIi527-B
(HPSI0216i-heub_6)
Donor diseases:
Usher syndrome
WTSIi474-B
(HPSI0216i-dewh_4)
Donor diseases:
Usher syndrome
WTSIi510-B
(HPSI0216i-xanu_6)
Donor diseases:
Usher syndrome
WTSIi548-B
(HPSI0416i-mefc_1)
Donor diseases:
Usher syndrome
WTSIi488-B
(HPSI0516i-oazw_3)
Donor diseases:
Usher syndrome
WTSIi464-B
(HPSI0516i-eitu_4)
Donor diseases:
Usher syndrome
WTSIi486-B
(HPSI0516i-hapz_2)
Donor diseases:
Usher syndrome
WTSIi669-A
(HPSI0816i-aorf_1)
Donor diseases:
Usher syndrome
WTSIi669-B
(HPSI0816i-aorf_2)
Donor diseases:
Usher syndrome
WTSIi453-A
(HPSI0416i-fiwt_3)
Donor diseases:
Usher syndrome
WTSIi464-A
(HPSI0516i-eitu_3)
Donor diseases:
Usher syndrome
WTSIi474-A
(HPSI0216i-dewh_6)
Donor diseases:
Usher syndrome
WTSIi486-A
(HPSI0516i-hapz_3)
Donor diseases:
Usher syndrome
WTSIi488-A
(HPSI0516i-oazw_4)
Donor diseases:
Usher syndrome
WTSIi510-A
(HPSI0216i-xanu_5)
Donor diseases:
Usher syndrome
WTSIi527-A
(HPSI0216i-heub_1)
Donor diseases:
Usher syndrome
WTSIi548-A
(HPSI0416i-mefc_2)
Donor diseases:
Usher syndrome
WTSIi576-A
(HPSI0216i-feht_1)
Donor diseases:
Usher syndrome
WTSIi450-B
(HPSI0216i-aiid_6)
Donor diseases:
Usher syndrome
WTSIi516-B
(HPSI0216i-iogu_6)
Donor diseases:
Usher syndrome
WTSIi447-B
(HPSI0416i-zige_2)
Donor diseases:
Usher syndrome
WTSIi522-B
(HPSI0516i-pews_2)
Donor diseases:
Usher syndrome
WTSIi454-B
(HPSI0516i-iool_4)
Donor diseases:
Usher syndrome
WTSIi447-A
(HPSI0416i-zige_5)
Donor diseases:
Usher syndrome
WTSIi450-A
(HPSI0216i-aiid_1)
Donor diseases:
Usher syndrome
WTSIi454-A
(HPSI0516i-iool_6)
Donor diseases:
Usher syndrome
WTSIi487-A
(HPSI0516i-goek_4)
Donor diseases:
Usher syndrome
WTSIi516-A
(HPSI0216i-iogu_5)
Donor diseases:
Usher syndrome
WTSIi522-A
(HPSI0516i-pews_3)
Donor diseases:
Usher syndrome
WTSIi485-B
(HPSI0614i-kecw_4)
Donor diseases:
Bardet-Biedl syndrome
WTSIi399-B
(HPSI0614i-gawh_12)
Donor diseases:
Bardet-Biedl syndrome
WTSIi415-B
(HPSI0614i-laig_2)
Donor diseases:
Bardet-Biedl syndrome
WTSIi033-A
(HPSI1013i-aetc_1)
Donor diseases:
Bardet-Biedl syndrome
WTSIi034-A
(HPSI0913i-kojv_2)
Donor diseases:
Bardet-Biedl syndrome
WTSIi035-A
(HPSI0913i-gooj_1)
Donor diseases:
Bardet-Biedl syndrome
WTSIi457-B
(HPSI0115i-iinu_5)
Donor diseases:
Bardet-Biedl syndrome
WTSIi399-A
(HPSI0614i-gawh_7)
Donor diseases:
Bardet-Biedl syndrome
WTSIi415-A
(HPSI0614i-laig_1)
Donor diseases:
Bardet-Biedl syndrome
WTSIi149-A
(HPSI0913i-laia_4)
Donor diseases:
Bardet-Biedl syndrome
WTSIi150-A
(HPSI0414i-jetz_1)
Donor diseases:
Bardet-Biedl syndrome
WTSIi419-A
(HPSI0514i-kidt_1)
Donor diseases:
Bardet-Biedl syndrome
WTSIi153-A
(HPSI0414i-puvg_1)
Donor diseases:
Bardet-Biedl syndrome
WTSIi422-A
(HPSI0414i-zazi_4)
Donor diseases:
Bardet-Biedl syndrome
WTSIi155-A
(HPSI0414i-hutq_1)
Donor diseases:
Bardet-Biedl syndrome
WTSIi156-A
(HPSI0414i-xugr_2)
Donor diseases:
Bardet-Biedl syndrome
WTSIi157-A
(HPSI0614i-eavo_1)
Donor diseases:
Bardet-Biedl syndrome
WTSIi426-A
(HPSI0714i-mejk_1)
Donor diseases:
Bardet-Biedl syndrome
WTSIi160-A
(HPSI0914i-verf_1)
Donor diseases:
Bardet-Biedl syndrome
Last update 8th December 2017
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Royan Institute (RI)
Derivation country Iran

External Databases

Cellosaurus CVCL_C373
Wikidata Q54991920

General Information

Publications
* Is the cell line readily obtainable for third parties?
Yes

Donor Information

General Donor Information

Sex female

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is affected.

Ethics

Do you (Depositor/Provider) hold the original Donor Consent Form? Yes
Alternatives to consent

hIPSC Derivation

General

Source cell type
A connective tissue cell which secretes an extracellular matrix rich in collagen and other macromolecules. Flattened and irregular in outline with branching processes; appear fusiform or spindle-shaped.; These cells may be vimentin-positive, fibronectin-positive, fsp1-positive, MMP-1-positive, collagen I-positive, collagen III-positive, and alpha-SMA-negative.

Reprogramming method

Vector type Integrating
Vector Virus (Retrovirus)
Genes
Is the used vector excisable?
Unknown
Absence of reprogramming vector(s)?
Unknown
Reprogramming vectors silenced?

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Surface coating Matrigel/Geltrex
CO2 Concentration 5 %
Medium Other medium:
Base medium: DMEM F/12
Main protein source: Knock-out serum replacement
Serum concentration: 20 %
Supplements
L-glutamine 2 mM
β-mercaptoethanol 0.1 mM
nonessential amino acid 1 %
penicillin 100 units/ml
streptomycin 100 µg/ml
insulin-transferrin-selenite
bFGF

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
NANOG
Yes
POU5F1 (OCT-4)
Yes
SSEA-3
Yes
SSEA-4
Yes
TRA 1-60
Yes
TRA 1-81
Yes
SOX2
Yes

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46XX

Other Genotyping (Cell Line)